首頁 › 間質性肺病 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 間質性肺病 臨床試驗
9 項針對 間質性肺病 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- University of Alabama at Birmingham, Birmingham
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中2 期
- University of Alabama, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- UAB Lung Health Center, Birmingham
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- University of Alabama at Birmingham, Birmingham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中觀察性研究
- University of Alabama at Birmingham, Birmingham
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中觀察性研究
- University of Alabama - Birmingham, Birmingham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- UAB Lung Health Center, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
招募中2 期
- University of Alabama at Birmingham, Birmingham
其他城市的 間質性肺病 試驗
- New York City, NY18 項研究
- Philadelphia, PA16 項研究
- Los Angeles, CA14 項研究
- Charleston, SC13 項研究
- Kansas City, KS13 項研究
- Durham, NC13 項研究
- Chicago, IL12 項研究
- Houston, TX12 項研究
- Aurora, CO11 項研究
- Ann Arbor, MI11 項研究
- Salt Lake City, UT9 項研究
- Dallas, TX9 項研究
Birmingham 的其他研究
- 癌症（所有類型）31 項研究
- 乳癌24 項研究
- 卵巢癌23 項研究
- 肥胖症23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 第二型糖尿病16 項研究
- 子宮內膜癌16 項研究
- 過重16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。